Sign inGet started

Maizel Ari

Insider CIK 2042289 · AXSM Chief Commercial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
AXSM Axsome Therapeutics, Inc. M Exercise deriv2026-04-222026-04-237,500— $023,710SEC↗
AXSM Axsome Therapeutics, Inc. M Exercise2026-04-222026-04-237,500$70.73 $530.5K7,500SEC↗
AXSM Axsome Therapeutics, Inc. S Sale2026-04-222026-04-237,500$182.42 $1.37M0SEC↗
AXSM Axsome Therapeutics, Inc. A Award deriv2026-04-212026-04-237,224— $07,224SEC↗
AXSM Axsome Therapeutics, Inc. A Award deriv2026-02-262026-02-2716,385— $016,385SEC↗
AXSM Axsome Therapeutics, Inc. M Exercise deriv2026-01-212026-01-237,500— $031,210SEC↗
AXSM Axsome Therapeutics, Inc. M Exercise2026-01-212026-01-237,500$70.73 $530.5K7,500SEC↗
AXSM Axsome Therapeutics, Inc. S Sale2026-01-212026-01-237,500$184.44 $1.38M0SEC↗
AXSM Axsome Therapeutics, Inc. A Award deriv2025-02-242025-02-257,740— $07,740SEC↗
AXSM Axsome Therapeutics, Inc. A Award deriv2025-02-212025-02-257,816— $07,816SEC↗
AXSM Axsome Therapeutics, Inc. A Award deriv2025-02-212025-02-257,740— $07,740SEC↗